Manchester-based health tech innovator SiSU Health has raised £1.25 million in funding from Praetura Ventures to expand its network of AI-driven health stations, designed to tackle preventable diseases and health inequalities through early intervention.
The investment, led by the GMC Life Sciences Fund by Praetura and Northern Powerhouse Investment Fund II (NPIF II) – Praetura Equity Finance, will support the rollout of more than 600 health stations across workplaces, NHS sites, and community hubs by 2026. The platform, which already serves 20,000 users monthly, enables five-minute self-service health checks, measuring blood pressure, BMI, and other key indicators to assess risks for chronic conditions like heart disease and diabetes.
READ MORE: Praetura launches new £3m+ North-focused Venture Capital Trust
SiSU Health’s data shows that over 70% of users had not had a recent blood pressure check—a leading risk factor for cardiovascular disease, highlighting gaps in traditional healthcare access. The platform focuses on early detection and prevention, particularly in underserved communities where health inequalities are most acute.
With 31% of working-age adults in the UK managing long-term health conditions – costing the economy £103bn annually (IPPR) – SiSU’s solution helps employers, insurers, and the NHS reduce absenteeism, improve productivity, and allocate resources more effectively.
The company has already partnered with major brands like Aldi, Jaguar Land Rover, and The AA, as well as NHS Trusts and local councils. It recently contributed to the Department of Health and Social Care’s CVD Workforce Health Check Programme and plans to launch a new Public Health proposition later this year.
READ MORE: Yorkshire AI tech start-up secures £250k to tackle one of hospitality’s biggest headaches
As part of its scaling strategy, SiSU will expand its Manchester operations, including manufacturing and logistics, while working with the Department for Business & Trade to secure larger premises. This investment marks the fifth co-investment between Praetura’s two funds in the past year, reinforcing their commitment to the North West’s life sciences sector.
Samantha Fay, CEO at SiSU Health, said: “We’re building a future where everyone has the tools and confidence to take control of their health — wherever they are. This funding allows us to scale our digital platform, extend our reach into new communities, and strengthen our collaborations and integrations across employer, public health and primary care. Prevention has to be proactive, accessible and data-informed — and that’s exactly what SiSU Health delivers.”
Sim Singh-Landa, head of the GMC Life Sciences Fund By Praetura, said the tech was “bringing health into the modern age by helping individuals to take a health test at a time that’s convenient to them without judgement and the costs that can be associated with health checks.”
“They are critically providing connected collaboration between the corporate world and public health systems,” they said. “Encouraging self-care and health awareness for individuals with supported follow-up and interventions, which has significant benefits for the NHS and public health. This latest co-investment between the GMC Life Sciences Fund By Praetura and NPIF II also shows the power of two well-established regional funders working together to help propel great companies in the region.”
Dr Kath Mackay, Chief Scientific Officer for Bruntwood SciTech, said: “The GMC Life Sciences Fund By Praetura was set up to grow the region’s life sciences footprint to new levels of widespread recognition and give support to innovative businesses like SiSU Health who are tackling challenges like public health and the need to reach underrepresented demographics.”
SiSU Health is still seeking investment ahead of closing its current fundraising round.
The GMC Life Sciences Fund By Praetura is a £20m investment fund by Greater Manchester Combined Authority, Enterprise Cheshire and Warrington, Bruntwood SciTech and Praetura Ventures. The fund was launched in May 2022 by the Mayor of Greater Manchester Andy Burnham and supports life sciences businesses based in the region or those who are committed to scaling here. The £660m Northern Powerhouse Investment Fund II (NPIFII) covers the entire North of England and provides loans from £25k to £2m and equity investment up to £5m to help a range of small and medium sized businesses to start up, scale up or stay ahead.
